Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 1/2 8Phase 1 4Phase 3 2Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2

Conditions

Leukemia, Myeloid, Acute 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myeloproliferative Disorders 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia, Lymphocytic, Chronic, B-Cell 5Myelodysplastic Syndromes 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Hodgkin Disease 4Graft vs Host Disease 4Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Waldenstrom Macroglobulinemia 2Primary Myelofibrosis 2Myasthenia Gravis 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Biphenotypic, Acute 2Leukemia 2Hematologic Neoplasms 2Anemia, Refractory, with Excess of Blasts 2Testicular Neoplasms 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neoplasms, Plasma Cell 1Neoplasms 1Myeloproliferative Syndrome, Transient 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Olanzapine 4Cyclophosphamide 4Voriconazole 3Tranexamic Acid 3Standard of Care 3nilotinib 2letermovir 2fludarabine phosphate 2Zoledronic Acid 2Whole-Body Irradiation 2Practice Guidelines as Topic 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Methods 2Imatinib Mesylate 2Educational Status 2Early Intervention, Educational 2Doxorubicin 2Cyclosporins 2Cyclosporine 2venetoclax 1trihexyltetradecylphosphonium chloride 1thymoglobulin 1shengxuening 1posaconazole 1pembrolizumab 1olaparib 1maribavir 1lenvatinib 1ferrous succinate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Hematologic Neoplasms × Mycophenolic Acid × Clear all
NCT01231412 2026-04-30

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

Fred Hutchinson Cancer Center

Phase 3 Completed
174 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00075478 2017-05-15

Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Fred Hutchinson Cancer Center

Phase 3 Completed
87 enrolled 16 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Chronic-Phase, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡